Farzana D Pashankar, MD, MRCP

Associate Professor of Pediatrics (Hematology / Oncology)

Clinical Interests

  • Anemia, Sickle Cell
  • Hematologic Diseases
  • Medical Oncology
  • Thalassemia

Patient Care

Accepts new patients? Yes
Patient Type: Child
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Pediatric Hematology & Oncology Program

Pediatrics: Pediatric Hematology & Oncology

Yale Medical Group

Board Certifications

  • Pediatric Hematology & Oncology AB of Pediatrics (2004)

Clinical Trials

Conditions Study Title
Brain and Nervous System LGG-14C03 A Phase III Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults with Previously Untreated Low Grade Glioma
Unknown Sites Genetic Aspects of Familial Malignancies
Ill-Defined Sites Umbrella Long-Term Follow-Up Protocol (COG ALTE05N1) (CIRB)
Lymphoid Leukemia Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (COG ALTE07C1) (CIRB)
Unknown Sites Key Adverse Events after Childhood Cancer (COG ALTE03N1)
Lymphoid Leukemia Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (AALL0932) (CIRB)
Soft Tissue Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma (COG AEWS1031)(CIRB)
Brain and Nervous System Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years (COG ACNS0831) (CIRB)
Bones and Joints, Brain and Nervous System, Hodgkin's Lymphoma, Kidney, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Male Genital, Soft Tissue Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Network (COG ACCRN07) (CIRB)
Soft Tissue A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol (COG 9902)
Brain and Nervous System Neuroblastoma Biology Studies (COG ANBL00B1) {CIRB}
Unknown Sites Study of Immune System in Patients with Cancer and Blood Disorders
Kidney National Wilms Tumor Late Effects Study (POG 9442)
Myeloid and Monocytic Leukemia AAML1031 A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for patients with High Allelic Ratio FLT3/ITD; A Groupwide II/III Study
Soft Tissue ANBL1221 A Phase II Randomized Trial of Irinotecan/Temozolomide with Temsirolimus (NSC#683864, IND#61010) or Chimeric 14.18 Antibody (ch 14.18) (NSC#623408, IND#4308) in Children with Refractory or Progressive Neuroblastoma
Leukemia, other ANHL1131 Intergroup trial for children or adolescents with B-cell NHL or B-AL: evaluation of Rituximab efficacy and safety in high risk patients
ALTE11C2: Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Preventionof Anthracycline-related Cardiomyopathy
ACCL1034 Impact of Cleansing with Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children with Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)
Eye and Orbit ARET12P1 A Multi-institutional Feasibility Study of Intra-Arterial Chemotherapy Given in the Ophthalmic Artery of Children with Retinoblastoma: A Limited Institution Pilot Study
Lymphoid Leukemia AALL1231 -- A Phase III Randomized Trial Investigating Bortezomib (NSC#681239; IND#58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL_ and T-Lymphoblastic Lymphoma (T-LLy) -- A Groupwide Phase III Study

Edit this profile

Contact Info

Farzana D Pashankar, MD, MRCP
Patient Care Location
Yale Pediatric Hematology & OncologySmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste 7th floor

New Haven, CT 06511
Mailing Address
PO Box 208064
New Haven, CT 06520-8064

Curriculum Vitae